Starvation promotes REV1 SUMOylation and p53-dependent sensitization of melanoma and breast cancer cells.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 25614517.
- Also identified by DOI 10.1158/0008-5472.CAN-14-2249 and PMC identifier 4359966.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Short-term starvation or fasting can augment cancer treatment efficacy and can be effective in delaying cancer progression in the absence of chemotherapy, but the underlying molecular mechanisms of action remain elusive. Here, we describe the role of REV1, a specialized DNA polymerase involved in DNA repair, as an important signaling node linking nutrient sensing and metabolic control to cell fate. We show that REV1 is a novel binding partner of the tumor suppressor p53 and regulates its activity. Under starvation, REV1 is modified by SUMO2/3, resulting in the relief of REV1's inhibition of p53 and enhancing p53's effects on proapoptotic gene expression and apoptosis in breast cancer and melanoma cells. Thus, fasting in part through its effect on REV1 is a promising nontoxic strategy to increase p53-dependent cell death and to enhance the efficacy of cancer therapies.
Medical subject headings
- Breast Neoplasms
- Melanoma
- Nuclear Proteins
- Nucleotidyltransferases
- Starvation
- Sumoylation
- Tumor Suppressor Protein p53